Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Regulatory News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

5 Oct 2017 11:12

RNS Number : 8215S
Clinigen Group plc
05 October 2017
 

5 October 2017

 

Issue of Equity

Clinigen Group plc (AIM: CLIN, the "Group") announces that it has made an application for the admission to trading on AIM of 814 ordinary shares of 0.1 pence each in the Group (the "New Ordinary Shares"), which have been issued to satisfy the exercise of share options and rank pari passu with the existing shares of the Group. Admission to trading on AIM of the New Ordinary Shares is anticipated to occur on 12 October 2017.

 

At admission the issued share capital of the Group will consist of 115,369,132 ordinary shares, with no shares held in treasury. The total number of voting rights in the Group will therefore be 115,369,132. This figure may be used by shareholders as the denominator to determine if they are required to notify their interests in, or a change to their interests in, the Group under the Disclosure Guidance and Transparency Rules.

 

-Ends-

 

Contact details

 

Clinigen Group plc

Tel: +44 (0) 1283 495010

Shaun Chilton, Group Chief Executive Officer

Martin Abell, Group Chief Financial Officer

Numis Securities Limited

Tel: +44 (0) 20 7260 1000

Michael Meade / Freddie Barnfield (Nominated Adviser)

James Black / Tom Ballard (Corporate Broking)

RBC Capital Markets - Joint Broker

Tel: +44 (0) 20 7653 4000

Marcus Jackson / Elliot Thomas / Jack Wood

Instinctif Partners

Tel: +44 (0) 20 7457 2020

Melanie Toyne-Sewell / Alex Shaw / Deborah Bell

Email: clinigen@instinctif.com

 

About Clinigen Group

Clinigen Group plc (AIM: CLIN) is a global pharmaceutical and services company with a unique combination of businesses focused on providing access to medicines. Its mission is to deliver the right medicine to the right patient at the right time through three areas of global medicine supply; clinical trial, unlicensed and licensed medicines.

 

For more information, please visit www.clinigengroup.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEFSAFSIFWSESS
Date   Source Headline
4th Apr 20224:54 pmRNSForm 8.5 (EPT/RI)-Clinigen Group plc_Amend
4th Apr 20223:29 pmRNSForm 8.3 - [Clinigen Group plc/Triley Bidco Ltd]
4th Apr 20223:20 pmRNSForm 8.3 - Clinigen Group plc
4th Apr 20223:20 pmRNSForm 8.3 - Clinigen Group plc
4th Apr 202212:31 pmGNWForm 8.3 - Clinigen Group PLC
4th Apr 202211:46 amGNWForm 8.3 - AXA INVESTMENT MANAGERS: Clinigen Group Plc
4th Apr 202211:09 amRNSForm 8.5 (EPT/RI)- Clinigen Group plc
4th Apr 202210:59 amGNWHSBC Bank Plc - Form 8.5 (EPT/RI) - Clinigen Group PLC
4th Apr 202210:50 amRNSScheme Becomes Effective
4th Apr 20229:50 amRNSForm 8.5 (EPT/NON-RI) Clinigen Group plc
4th Apr 20229:19 amRNSForm 8.5 (EPT/RI) - Clinigen Group Plc
4th Apr 20227:30 amRNSSuspension - Clinigen Group PLC
1st Apr 20223:29 pmRNSForm 8.3 - Clinigen Group plc
1st Apr 20223:25 pmRNSForm 8.3 - Clinigen Group
1st Apr 20223:20 pmRNSForm 8.3 - Clinigen Group plc
1st Apr 20223:00 pmRNSForm 8.3 - Clinigen Group plc
1st Apr 20221:27 pmGNWForm 8.3 - Clinigen Group PLC
1st Apr 20221:09 pmRNSForm 8.5 (EPT/RI)-Clinigen Group plc
1st Apr 202210:59 amRNSForm 8.5 (EPT/NON-RI)-CLINIGEN GROUP PLC
1st Apr 202210:52 amGNWHSBC Bank Plc - Form 8.5 (EPT/RI) - Clinigen Group PLC
1st Apr 202210:22 amRNSForm 8.5 (EPT/RI) - Clinigen Group PLC
1st Apr 20229:56 amRNSForm 8.3 - Clinigen Group Plc
31st Mar 20225:52 pmRNSForm 8.5 (EPT/RI)- Clinigen Group plc Amend
31st Mar 20223:30 pmGNWForm 8.3 - Clinigen Group plc
31st Mar 20223:29 pmRNSForm 8.3 - Clinigen Group plc
31st Mar 20223:27 pmRNSForm 8.3 - Clinigen Group plc
31st Mar 20223:20 pmRNSForm 8.3 - Clinigen Group plc
31st Mar 202212:54 pmRNSCourt Sanction of Scheme of Arrangement
31st Mar 202212:52 pmGNWForm 8.3 - Clinigen Group PLC
31st Mar 202211:11 amRNSForm 8.3 - CLINIGEN GROUP PLC
31st Mar 202211:09 amGNWHSBC Bank Plc - Form 8.5 (EPT/RI) - Clinigen Group PLC
31st Mar 202210:48 amRNSForm 8.5 (EPT/RI)- Clinigen Group plc
31st Mar 202210:41 amRNSForm 8.5 (EPT/NON-RI) Clinigen Group plc
31st Mar 202210:10 amRNSForm 8.3 - Clinigen Group Plc
30th Mar 20225:30 pmRNSClinigen Group
30th Mar 20223:21 pmRNSForm 8.3 - Clinigen Group Plc
30th Mar 20223:20 pmRNSForm 8.3 - Clinigen Group plc
30th Mar 20222:42 pmRNSForm 8.3 - Clinigen Group Plc
30th Mar 20221:44 pmGNWForm 8.3 - Clinigen Group PLC
30th Mar 202211:45 amRNSForm 8.5 (EPT/NON-RI)- Clinigen Group plc
30th Mar 202211:37 amRNSForm 8.5 (EPT/RI)- Clinigen Group plc
30th Mar 202211:19 amGNWHSBC Bank Plc - Form 8.5 (EPT/RI) - Clinigen Group PLC
30th Mar 202210:49 amRNSForm 8.3 - Clinigen Group PLC
30th Mar 202210:35 amRNSForm 8.5 (EPT/NON-RI) Clinigen Group plc
30th Mar 202210:34 amRNSForm 8.3 - Clinigen Group Plc
29th Mar 20223:20 pmRNSForm 8.3 - Clinigen Group plc
29th Mar 20222:48 pmRNSForm 8.3 - Clinigen Group Plc
29th Mar 20222:43 pmRNSForm 8.3 -Clinigen Group plc
29th Mar 20221:30 pmBUSForm 8.3 - CLINIGEN GROUP PLC
29th Mar 202212:55 pmGNWForm 8.3 - Clinigen Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.